INSULET (GOV MU) stock market data APIs
€121.65
0.24(0.2%)
as of September 21, 2026
Try our APIs with
free plan!
INSULET Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for GOV.MU.
Prev. Close
121.65
Open
121.8938
High
121.8986
Low
121.1691
52 wk Range
113.6-302.5
Market Cap
16 032 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get INSULET data using free add-ons & libraries
Get INSULET Fundamental Data
INSULET Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
INSULET News
New
Insulet to Participate in Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum
ACTON, Mass., September 18, 2026--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that ...
BCSM Exits Insulet Corporation (PODD), Maintains Watchlist Status
Baron Capital, an investment management company, released its second-quarter 2026 investor letter for its "Baron SMID Cap ETF". You can download the letter here. Baron SMID Cap ETF® (BCSM) gained 15....
2 S&P 500 Stocks with Impressive Fundamentals and 1 We Turn Down
2 S&P 500 Stocks with Impressive Fundamentals and 1 We Turn Down The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn't mean every stock is worth owning. Some compan...
Is it Prudent to Retain Insulet Stock in Your Portfolio for Now?
Insulet PODD is well poised for growth in the upcoming quarters, owing to its strong momentum for the Omnipod 5 automated insulin delivery ("AID") system for both Type 1 and Type 2 populations. The co...
Get INSULET fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
